本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Theravance Biopharma Inc.

16.78
+0.14000.84%
盤後17.230.4527+2.70%18:29 EDT
成交量:52.68萬
成交額:873.70萬
市值:8.64億
市盈率:8.15
高:16.80
開:16.58
低:16.36
收:16.64
52周最高:21.03
52周最低:8.33
股本:5,149.29萬
流通股本:2,184.42萬
量比:1.48
換手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):2.06
每股收益(LYR):2.06
淨資產收益率:44.85%
總資產收益率:-0.54%
市淨率:2.91
市盈率(LYR):8.15

資料載入中...

2021/04/28

重要事件披露

8-K - Current report
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/31

重要事件披露

8-K - Current report
2021/03/16

重要事件披露

8-K - Current report
2021/03/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/23

重要事件披露

8-K - Current report
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/09/14

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals